Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Trial Profile

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms ARTEMIS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 18 Nov 2019 Results (n=6135) assessing copayment assistance interventions utilized when available and their impact on medication persistence were presented at the American Heart Association Scientific Sessions 2019
    • 01 Jan 2019 Results assessing the co-payments impact on P2Y12 inhibitor use and major cardiovascular events published in the JAMA: the Journal of the American Medical Association
    • 14 Nov 2018 Results assessing the "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications, presented at the 91st Annual Scientific Sessions of the American Heart Association
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top